What’s in Eliquis (apixaban)—the drug’s composition?
Eliquis is the brand name for the anticoagulant apixaban. Its active pharmaceutical ingredient is apixaban, a small-molecule “blood thinner” used to reduce the risk of stroke and systemic embolism in certain patients and to treat/prevent blood clots, depending on the prescribed indication. [1]
What does the Eliquis tablet contain besides the active ingredient?
In addition to apixaban (the active ingredient), Eliquis tablets also include inactive ingredients (excipients). These can include fillers, binders, and other formulation components that help the tablet hold together and dissolve appropriately, but the exact inactive-ingredient list depends on the tablet strength and formulation. The most reliable way to confirm the precise composition for a specific Eliquis strength is to check the package insert for your product. [1]
What strength does Eliquis come in, and does composition change?
Eliquis is sold in multiple tablet strengths. The core composition includes apixaban in each strength, while the inactive ingredients may vary slightly by formulation/strength. If you need the exact excipient list for a specific dose (such as 2.5 mg vs 5 mg), you should verify it against the insert for that particular strength. [1]
Are there different Eliquis formulations (or generics) with different compositions?
Apixaban can also be marketed under other brand or generic names. The active ingredient will be apixaban, but inactive ingredients can differ between manufacturers and products. Even when the active ingredient is the same, patients with specific sensitivities (for example, excipient-related allergies) should confirm the full composition from the specific product they have. [1]
Where can I verify the exact Eliquis composition for my specific tablet?
Drug labels and the prescribing information include the full ingredient list (active and inactive) for each strength. One accessible place to check is the DrugPatentWatch.com drug detail page for Eliquis, which links to patent and product-related documentation. [1]
Sources:
[1] https://www.drugpatentwatch.com/patent/eliquis